CAS 958002-36-3

Beclabuvir hydrochloride

CAS: 958002-36-3

Beclabuvir is a piperazine derivative that is used as an antiviral drug. It has been shown to inhibit the replication of hepatitis C virus (HCV) in cell culture, and inhibits the reactivation of HCV in patients treated with pegylated interferon-α2a and ribavirin. Beclabuvir has also been shown to inhibit the production of reactive oxygen species, which are involved in many cellular processes, including cell signaling and proliferation. In addition, beclabuvir has been shown to have antiviral activity against HIV-1.
The reaction rate for this compound can be increased by adding an oxidizing agent such as hydrogen peroxide or peroxydisulfate. Beclabuvir has functional groups such as hydroxyl and carboxyl groups, which are more reactive than other functional groups such as amino or thiol groups. The oxidation products of beclabuvir include hydroxylamine, nit

Fórmula: C₃₆H₄₆ClN₅O₅S

Pureza: Min. 95%

Peso molecular: 696.3 g/mol

Ref: 3D-INB00236

Beclabuvir HCl

CAS: 958002-36-3

Beclabuvir (BMS-791325) is an HCV inhibitor targeting NS5B polymerase with sub-28 nM potency for genotypes 1, 3, 4, 5.

Fórmula: C₃₆H₄₆ClN₅O₅S

Forma y color: Solid

Peso molecular: 696.3

Ref: TM-T68235